Artiva Biotherapeutics In... (ARTV)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
7.06
0.53 (8.12%)
At close: Jan 21, 2025, 3:59 PM
7.07
0.14%
After-hours Jan 21, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | 33.49M | 4.93M | 2.00M | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | 33.49M | 4.93M | 2.00M | n/a |
Operating Income | -30.67M | -59.83M | -53.27M | -18.27M |
Interest Income | 2.54M | 1.29M | n/a | 2.00K |
Pretax Income | -27.62M | -58.34M | -71.83M | -17.99M |
Net Income | -27.70M | -58.39M | -71.83M | -17.99M |
Selling & General & Admin | 13.91M | 20.78M | 12.86M | 4.43M |
Research & Development | 50.25M | 43.98M | 42.41M | 13.85M |
Other Expenses | n/a | 200.00K | -18.55M | 477.00K |
Operating Expenses | 64.16M | 64.76M | 55.27M | 18.27M |
Interest Expense | n/a | n/a | n/a | 199.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 64.16M | 64.76M | 55.27M | 18.27M |
Income Tax | 72.00K | 53.00K | -18.55M | 676.00K |
Shares Outstanding (Basic) | 9.35M | 17.58M | 17.58M | 17.58M |
Shares Outstanding (Diluted) | 9.35M | 17.58M | 17.58M | 17.58M |
EPS (Basic) | -2.96 | -3.32 | -4.08 | -1.02 |
EPS (Diluted) | -2.96 | -3.32 | -4.08 | -1.02 |
EBITDA | -28.41M | -58.67M | -71.58M | -17.72M |
Depreciation & Amortization | 2.27M | 1.16M | 248.00K | 73.00K |